Home  >  Products  >  ACVR1C (activin A receptor, type IC) Blocking Peptide (the N terminal of protein) (100ug)
ACVR1C (activin A receptor, type IC) Blocking Peptide (the N terminal of protein) (100ug)

ACVR1C (activin A receptor, type IC) Blocking Peptide (the N terminal of protein) (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-ACVR1C antibody (Catalogue #: ARP52836_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP52836
Size: 100 ug
Weight: 55kDa
Gene: 130399
Format: Lyophilized powder
Target: ACVR1C is a type I receptor for the TGFB family of signaling molecules. Upon ligand binding, type I receptors phosphorylate cytoplasmic SMAD transcription factors, which then translocate to the nucleus and interact directly with DNA or in complex with other transcription factors.ACVR1C is a type I receptor for the TGFB (see MIM 190180) family of signaling molecules. Upon ligand binding, type I receptors phosphorylate cytoplasmic SMAD transcription factors, which then translocate to the nucleus and interact directly with DNA or in complex with other transcription factors (Bondestam et al., 2001 [PubMed 12063393]).[supplied by OMIM].
Alternative names: ACVRLK7; ALK7
See Full Product Listings >